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Background: Because in many locations the demand for sleep studies exceeds
resources, we evaluated the utility of split-day in-laboratory studies (SDS) in highly
selected patients.
Methods: We studied 100 eligible cases: 68 males (age 48.671.3 [standard error, SE]
years, body mass index (BMI): 32.670.8 kg/m2) and 32 females (age 50.972.4 years,
BMI: 36.371.3 kg/m2) with severe subjective sleepiness (Epworth sleepiness scale:
ESSX16) and suspected obstructive sleep apnea syndrome (OSAS).
Results: There were 86 conclusive studies that yielded both a diagnosis and
sufficient information for management (86.0%) and 14 inconclusive studies that did
not yield sufficient information for management (14.0%). In six cases (6.0%) with an
inconclusive study a diagnosis was made, however, no titration data was obtained.
Thus a definitive diagnosis was obtained in 92.0% of all cases. Those with
inconclusive studies had additional assessment, and eight of them ultimately had
a final diagnosis of a sleep breathing disorder (SBD) and six had another sleep
disorder: four had narcolepsy, one had a movement disorder, one had sleep
deprivation. Thus there were six patients (6.0%) in whom SDS yielded only an SBD
diagnosis but there was insufficient data for titration; two patients (2.0%) who
ultimately had severe OSAS who were not diagnosed on SDS.
Conclusions: SDS was found to be useful in the evaluation and treatment of highly
selected patients with severe daytime sleepiness (ESSX16) and suspected OSAS.
& 2005 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserv
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Because the prevalence of sleep apnea is high
(2–4% of the adult population),1 and may be risinged.
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many countries the laboratory resources to evalu-
ate patients are inadequate to meet clinical
demands.2 Because of lack of capacity to perform
nocturnal monitoring to meet the demand we
performed split-day in-laboratory studies (SDS) in
patients highly selected to have obstructive sleep
apnea, and who had severe subjective sleepiness
and would most likely sleep during daytime
evaluation. We present our experience using these
types of studies.Methods
Patients
We selected only patients suspected of having a
sleep breathing disorder (SBD) who had severe
subjective sleepiness, snoring, and witnessed ap-
nea. The Epworth sleepiness scale (ESS) was used to
quantify subjective daytime sleepiness.3 Only
patients with ESSX16 were selected in order to
increase the probability that they would sleep in
the daytime for a prolonged period of time. One
hundred consecutive eligible cases underwent SDS
and their data were analyzed.
Split-day in-laboratory study
The SDS included comprehensive polysomnography
which included the monitoring of neurophysio-
logical measures (EEG, chin EMG, EOG, anterior
tibialis EMG) and cardiorespiratory variables: chest
wall motion, abdominal motion, nasal pressure,
oronasal CO2, SpO2 (by ear oximeter), and EKG.
Nasal pressure, oronasal CO2, chest wall, and
abdominal motion were used to assess the respira-
tory events. All data were acquired on the W-Sleep
system Version 1.01 (Compumedics Ltd., Australia)
and included synchronized digital video recording.
Video records were used for additional assessment
for SBD. The sleep record was analyzed manually
using a 30 s epoch.4 Abnormal sleep breathing
events were defined using recognized criteria.5
The hourly number of episodes of apnea and
hypopnea was calculated as the apnea–hypopnea
index (AHI).
Patients upon arriving at the sleep laboratory mid
morning were instrumented, then were allowed to
sleep. The minimum sleep time to establish the
diagnosis was defined as 1 h. However, patients
with severe apnea confirmed by repetitive oxygen
desaturations below 80% and/or with cardiac
arrhythmias had less sleep time for the assessmentof baseline sleep. Once a SBD diagnosis was made,
manual CPAP titration was performed. CPAP was
started at 3 cmH2O and increased gradually by
1 cmH2O until apneas, hypopneas, and arousals
associated with abnormal breathing events includ-
ing snoring were eliminated. We did not define
minimum sleep time to titrate the optimal pres-
sure, but patients on CPAP were titrated until
apneas, hypopneas, and sleep-related arousals
during sleep in the supine position were abolished.
Patients with an SBD diagnosis who could not be
titrated, or patients without a definitive diagnosis,
were restudied with nighttime evaluation.
Diagnosis of sleep breathing disorders
The diagnosis of SBD was based on the patient’s
history and polysomnographic findings. AHI was
used as the indicator of sleep apnea severity. The
patients with obstructive sleep apnea syndrome
(OSAS) were classified into three groups according
to the different apnea severity (AHI); mild OSAS:
5–15 events per hour, moderate OSAS: 15–30 events
per hour, severe OSAS: greater than 30 events per
hour. The definition and diagnosis of sleep hypo-
ventilation syndrome (SHVS) were based on the
essential features and diagnostic criteria.5 The
definition and diagnosis of upper airway resistance
syndrome (UARS) were based on the essential
features.6,7 Cheyne–Stokes respiration (CSR) was
defined as a gradual waxing and waning of respira-
tion followed by a central apnea or central
hypopnea, described in detail elsewhere.5
Diagnoses of other primary sleep disorders
When studies were inconclusive and narcolepsy was
suspected, patients underwent multiple sleep
latency test (MSLT) by the conventional method8
to establish the diagnosis if there was any ambi-
guity about the diagnosis. All the patients who
received the diagnosis of narcolepsy met the
criteria by the guidelines of the International
Classification of Sleep Disorders Diagnostic and
Coding Manual.9 The diagnosis of restless legs
syndrome (RLS) was based on the essential
features.10
Classification of study outcomes
A conclusive study was defined as one which yielded
the information needed for management in the
case of a SBD: a diagnosis and response to
treatment (CPAP or oxygen). An inconclusive SDS
was defined as one which did not result in enough
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ment. A study was inconclusive if it did not yield a
diagnosis or treatment.
Statistical methods
All data are expressed as mean7standard error
(SE). For some values, the median is also presented.
For continuous variables, the Mann–Whitney U-test
was used. Frequency analysis was used with Fisher’s
exact probability test. One-way ANOVAwas used for
the analysis of the baseline SDS data, because there
were four groups determined by the result of SDS.
Significance of individual differences was evaluated
by the Tukey–Kramer test. Baseline polysomno-
graphic results of patients with SBD who underwent
CPAP titration were compared with those on
treatment, by means of Wilcoxon’s signed rank
test. Significance levels were set at Po0:05 and
Po0:01: Statistical analysis was done with StatView
software Version 5.0 (SAS institute Inc., Cary, NC,
USA).Results
Clinical presentation
We analyzed the data of 100 consecutive patients
(68 males and 32 females) suspected of a SBD
(Table 1).
Sleep disorders
SDS yielded a diagnosis in 92.0% of the patients.
There were 86 conclusive studies (86.0%) and 14
inconclusive studies (14.0%) confirmed by SDS
(Fig. 1). Among those 14 with an inconclusive SDS,
after nocturnal sleep study and/or MSLT, there
were eight patients with a final SBD diagnosis andTable 1 Characteristics of 100 consecutive cases suspec
No. of cases
Age (y/o)
BMI (kg/m2)**
ESS
Snoring*
Observed apnea*
Narcolepsy-related symptom
OSAS: obstructive sleep apnea syndrome, BMI: body mass index,
cataplexy, hypnagogic hallucinations, dreaming during nap.
*Po0:05; **Po0:01:six patients with another sleep disorder or sleep
deprivation. There were six patients (6.0%) in
whom SDS yielded only a diagnosis (no titration
data): severe OSAS (5), CSR caused by chronic heart
failure (1) and two patients (2.0%) who ultimately
had severe OSAS who were not diagnosed on SDS.
The reason why these patients needed another
study was insufficient time for CPAP titration (5) or
response to oxygen (one patient with CSR). In
two patients ultimately found to have severe
OSAS, SDS did not yield a diagnosis, because one
slept mainly on his side and the other did not sleep
long enough to assess SBD correctly. Of the six
patients ultimately having a non-SBD diagnosis,
four patients had narcolepsy, who needed an MSLT
for a further assessment, a patient had RLS and
periodic limb movements in sleep (PLMS) documen-
ted by subsequent nocturnal sleep study, and a
patient was ultimately diagnosed with sleep depri-
vation after excluding other causes of sleep
disorders by performing nocturnal sleep study and
MSLT.Polysomnographic findings
Table 2 shows the results of baseline polysomno-
graphic findings by SDS. Of the 79 patients who had
SBD, 73 patients underwent CPAP titration. They
spent 69.173.6min, median 67.5min asleep during
baseline and 84.776.0min, median 79.5min
asleep during CPAP titration. Six patients with mild
SBD were not titrated with CPAP, because baseline
polysomnographic data did not show abnormal
findings enough to be treated with CPAP. They were
ultimately recommended an oral appliance or
weight loss as an optimal treatment. Thirty-two
patients had REM sleep before treatment, and 48
patients had REM sleep on CPAP. Slow wave sleep
(stages 3 and 4) increased from 8.771.5% before
treatment to 19.072.2% on CPAP (Po0:01). REMted of OSAS and severe sleepiness.
Male Female
68 32
48.671.3 50.972.4
32.670.8 36.371.3
18.970.3 18.370.4
66 (97.1%) 27 (84.4%)
58 (85.3%) 20 (62.5%)
5 (7.4%) 6 (18.8%)
ESS: Epworth sleepiness scale, Narcolepsy-related symptom:
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Conclusive study  
N=86 (86.0%) 
Inconclusive study  
N=14 (14.0%) 
SBD  
N=79 (79.0%) 
Non SBD
N=7 (7.0%)
SBD
N=8  (8.0%) 
Non SBD
N=6 (6.0%) 
Mild OSAS
Moderate OSAS
Severe OSAS
SHVS
CSR
UARS
Narcolepsy
RLS 
∗Others
Yielded diagnosis
No titration data
N=6 (6.0%)
Did not yield diagnosis 
N=2 (2.0%)
Severe OSAS 5   (83.3%)
CSR 1  (16.7%)
Severe OSAS Narcolepsy 
RLS 
Sleep deprivation
Needed MSLT 
N=6 (6.0%)
Outcome of SDS
Final diagnosis
Performance of SDS
Repeat nocturnal sleep study
and other assessments
Yielded diagnosis
and treatment
N=86 (86.0%)
All patients  
N=100 (100%) 
14   (17.7%)
31   (39.2%)
3    (3.8%)
2    (2.5%)
2    (2.5%)
1  (14.3%)
2  (28.6%)
4  (57.1%)
27   (34.1%)
1   (16.7%)
1   (16.7%) 
4   (66.7%)2   (100.0%)
Figure 1 Diagnoses determined by split-day in-laboratory study (SDS). SBD: sleep breathing disorder, OSAS: obstructive
sleep apnea syndrome, SHVS: sleep hypoventilation syndrome, CSR: Cheyne–Stokes respiration, UARS: upper airway
resistance syndrome, RLS: restless legs syndrome, MSLT: multiple sleep latency test. *Drug side effect, sleep
deprivation and snoring.
Table 2 Baseline SDS data (see Fig. 1).
Conclusive study Inconclusive study
SBD Non-SBD Diagnostic only Non-diagnostic
No of cases 79 7 6 8
Time in bed (min) 107.274.5 (106.0) 195.1724.1 (174.5) 78.5711.5 (73.5) 205.8728.2 (228.5)
Total sleep time (min) 69.773.4 (69.0) 116.9726.7 (106.5) 42.376.5 (40.8) 132.8727.4 (131.0)
Sleep latency (min) 14.271.8 (8.5) 22.374.4 (28.5) 10.774.3 (10.0) 24.177.3 (17.0)
REM sleep latency (min) 64.176.0 95.3722.3 18 79.5711.3
No. of cases who had REM sleep 32 5 1 4
Sleep efficiency (%) 67.672.3 (73.5) 58.079.4 (63.9) 54.275.0 (52.1) 61.979.8 (70.2)
% Stage 1 20.271.9 12.272.7 23.077.0 25.2710.2
% Stage 2 63.072.0 64.874.7 74.176.8 53.976.8
% Stage SWS 8.971.6 8.573.3 1.070.8 12.573.7
% Stage REM 7.671.3 14.676.0 1.971.9 8.474.0
Leg movement index (h) 22.273.9 (6.2) 10.675.6 (1.7) 47.8728.8 (17.4) 8.976.2 (3.7)
Arousal index (/h) 45.873.1 (39.3) 42.276.6 (44.0) 59.079.8 (59.4) 24.873.7 (22.3)
AHI (/h) 37.573.9 (23.7) 1.870.7 (1.9) 45.2713.9 (43.1) 11.177.2 (0.5)
Average desaturation (%) 3.470.3 2.070 3.370.6 2.170.4
%SpO2o90% 6.972.0 0 2.972.0 0
SBD: sleep breathing disorder, SDS: split-day in-laboratory day study, SWS: stages 3 and 4, AHI: apnea–hypopnea index.
For some values, the median is presented.
Split-day studies 1337sleep was also increased: 7.671.4% before treat-
ment vs. 17.972.0% on CPAP (Po0:01). The AHI
decreased with CPAP from 38.974.1 before treat-
ment to 5.471.1/h (Po0:001). Arousal index wasimproved on CPAP: 46.873.3 before treatment vs.
19.571.9/h (Po0:001). Respiratory arousal index
also decreased with CPAP from 20.372.7 before
treatment to 0.870.2/h (Po0:001).
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To our knowledge, this is the first report of SDS for
suspected very sleepy SBD patients. We found that
SDS was useful in this group of highly selected
patients to establish SBD diagnosis and medical
management. Some researchers previously as-
sessed the validity of day studies and some found
this to be useful in the diagnosis of SBD.11–17 These
previous reports have focused on whether the day
studies can yield the appropriate information to
make the correct diagnosis. In terms of diagnostic
yield of SDS, our results (92.0% diagnostic) were
higher than that of other reports. The reason might
be explained by the inclusion criteria for our SDS
which is different from the other studies which
selected the patients based on just clinical suspi-
cion of having OSAS (e.g. daytime sleepiness, loud
snoring, observed apnea, overweight). All our
patients had severe daytime sleepiness with
ESSX16.
SDS was also useful for CPAP titration. We
demonstrated that during SDS the CPAP improved
AHI, arousal index, and respiratory arousal index.
Daytime CPAP titration studies have been success-
fully performed in patients with severe OSAS.18,19
Lloberes et al. reported that daytime CPAP titration
after sleep deprivation in unselected patients with
OSAS was useful.20 However, their protocol was not
split-day protocol. A single split-night protocol to
establish an effective CPAP by Iber et al. was
reported to be sufficient in 78% of the cases.21 Our
study yielded 86.0% conclusive studies; however,
further studies are required to clarify the long-term
outcome in the patients who were prescribed a
CPAP titrated by SDS.
There are two major problems in SDS which make
some studies inconclusive. One problem is that the
total sleep time in SDS is shorter than that of
overnight sleep study. We defined an inconclusive
study as the study which did not provide sufficient
information for medical management. Sanders et
al. concluded that polysomnography during 2 h of
sleep may be an appropriate method for evaluating
SBD.22 However, their study was focused on
whether a short sleep study can provide an
appropriate diagnosis or not. Our SDS showed that
six of eight patients diagnosed with SBD needed
more time for CPAP titration, although the diag-
nosis was made. It is possible that more sleep time
might be needed to determine therapeutic deci-
sions. The other reason which influences the
validity of SDS in patients suspected of having SBD
is that some patients may end up having another
diagnosis. Some patients with an inconclusive study
needed an additional nocturnal sleep study and anMSLT for a further assessment because they were
ultimately suspected of having narcolepsy. Four
patients (4.0%) with an inconclusive study ulti-
mately had narcolepsy. Goode et al. reported that
49 (15.8%) of 310 patients studied with a day sleep
study had narcolepsy.16 Johns reported that the
average ESS in patients with narcolepsy was
17.573.5, and was 11.774.6 in patients with
OSAS.3 Because we used a sleepiness (ESS) inclusion
criteria as well as the existence of symptoms
suggesting OSAS, some patients with narcolepsy
were included. Thus, our experience indicates that
SDS may be more valid if we exclude patients with
narcolepsy symptoms.
On the surface it might appear as though such an
approach might save operating costs in a labora-
tory. Although this would allow for more efficient
use of equipment and space, by far, the greatest
costs in a sleep laboratory are related to personnel
and the patients still require close attendance by
highly trained polysomnographic personnel. Stan-
dard polysomnography in an attended setting is still
recommended in the evaluation of SBD from the
viewpoint of evidence-based medicine; recent
assessments concluded there was not enough
rigorous evidence to support using unattended
simplified respiratory devices to reliably rule out
or in SBD.23,24 Therefore, compared to the un-
attended simplified respiratory recording which is
widely used in many countries outside North
America, a split-day approach may provide more
information regarding diagnosis or medical man-
agement and also be as useful as a nocturnal sleep
study. This approach may be cost-effective in
selected cases.References
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